Status:
UNKNOWN
Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza
Lead Sponsor:
University Health Network, Toronto
Conditions:
Influenza
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
A Pilot Study to Evaluate the Safety and Efficacy of interferon-Alfacon1 (INFERGEN) in the treatment of patients hospitalized with Influenza-like illness caused by a novel swine origin Influenza virus...
Detailed Description
The purpose of this study is to see if using a medication called INFERGEN, can help get rid of the virus and/or can help the immune response to prevent the illness from getting worse in the lungs. We ...
Eligibility Criteria
Inclusion
- Able to provide informed consent
- Aged \>=18 and \< 70
- Hospitalized
- suspect, probable, confirmed influenza A
- symptom onset \<8 days
- able to attend all scheduled visits
Exclusion
- known hypersensitivity to interferon preparation
- pregnancy
- chronic liver disease
- moderate to severe congestive heart failure, grade III or IV left ventricular function
- previous history of serious psychiatric illness
- history of severe or active autoimmune disease
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2011
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01227798
Start Date
November 1 2010
End Date
November 1 2011
Last Update
October 25 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2C4